Employment among patients with schizophrenia is known to positively influence patients’ recovery. In their crucial supporting role for patients, caregivers’ burden of care and quality of life may also be influenced by the employment status of patients. This study aimed to investigate the association between employment among patients with schizophrenia and burden and quality of life (QOL) of their caregivers. It was a cross-sectional survey among the primary caregivers of patients meeting DSM-IV-TR’s diagnostic criteria for schizophrenia who were under outpatient or community care at Hospital Bahagia Ulu Kinta. Socio-demographic data, including patients’ employment status, were collected. The Burden on Family Interview Schedule (BFS) and the 36-Item Short Form (SF-36) questionnaires were used to evaluate caregiver burden and quality of life, respectively. Altogether, 201 primary caregivers of patients with schizophrenia participated. Most caregiver burden was experienced in the aspects of finance and routine family activities. There was significant association between patient employment status (p
Soal-selidik Kecelaruan Keresahan Menyeluruh-7 (GAD-7) versi Bahasa Melayu telah menunjukkan kesahan bersamaan, iaitu kepekaan dan kekhususan yang tinggi sebagai alat saringan untuk keresahan. Namun, ciri-ciri psikometriknya dari segi kesahan faktor belum lagi dikaji dengan lebih lanjut. Kajian ini memeriksa struktur faktor GAD-7 versi Bahasa Melayu di antara 300 orang pesakit luar kencing manis (purata umur: 60.4 tahun, sisihan piawai: 13.4 tahun; 52.7% lelaki) di sebuah hospital universiti di Kuala Lumpur, Malaysia. Peserta kajian mengisi soal-soal selidik tentang maklumat sosiodemografik, GAD-7, Inventori Kemurungan Beck (BDI), dan WHOQOL-BREF. GAD-7 versi Bahasa Melayu menunjukkan konsistensi dalaman yang baik (Alfa Cronbach=0.91) dan kesahan konvergen yang tinggi dengan kemurungan (R Pearson=0.642, p
Comorbid adult attention-deficit hyperactivity disorder (ADHD) and stimulant dependence is widely recognized, but efficacy of pharmacotherapy in this patient population is not well established. We aimed to review whether pharmacotherapy is efficacious in reducing ADHD symptoms and stimulant use in comorbid adult ADHD and stimulant use disorder. English articles until June 2017 were systematically searched in electronic databases (MEDLINE and PsycINFO), an online clinical trials register (ClinicalTrial.gov), and through hand-search of article references. Randomized, double-blind, placebo-controlled trials that studied efficacy of pharmacotherapy in adults with comorbid ADHD and stimulant dependence were included. Two reviewers assessed studies for inclusion and extracted data; disagreements were resolved by consensus. Study outcomes included were changes in ADHD symptom severity, substance abstinence, treatment retention rates and safety. From the 1394 records identified, five trials (n=358) were included. Four studies involved methylphenidate; in another study extended-release mixed amphetamine were used. The comorbid stimulant was cocaine in three studies, and amphetamines in the rest. All were short-term studies involving predominantly young male adults conducted in outpatient settings. There is early promising but mixed evidence for therapeutic efficacy in improving ADHD symptoms. Stimulant medications did not worsen stimulant dependence or adverse effects of stimulant medications. Side effects were mild and tolerable. High attrition rates and small sample size limited the generalizability of findings. Current limited evidence suggests that stimulant treatment for comorbid adult ADHD and stimulant dependence is feasible. Welldesigned trials with adequate power are needed for more robust evidence on ADHD and stimulant use outcomes.